A detailed history of Montecito Bank & Trust transactions in Novo Nordisk A S stock. As of the latest transaction made, Montecito Bank & Trust holds 3,861 shares of NVO stock, worth $333,667. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,861
Previous 3,296 17.14%
Holding current value
$333,667
Previous $392,000 15.31%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$85.0 - $120.04 $48,025 - $67,822
565 Added 17.14%
3,861 $332,000
Q3 2024

Oct 31, 2024

BUY
$119.07 - $145.42 $47,628 - $58,167
400 Added 13.81%
3,296 $392,000
Q2 2024

Jul 17, 2024

SELL
$122.71 - $146.91 $38,530 - $46,129
-314 Reduced 9.78%
2,896 $413,000
Q1 2024

Apr 09, 2024

BUY
$102.11 - $135.92 $327,773 - $436,303
3,210 New
3,210 $412,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Montecito Bank & Trust Portfolio

Follow Montecito Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montecito Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Montecito Bank & Trust with notifications on news.